RADX Independent Test Assessment Program for MPOX Lesion Panel - Validation Center
- Funded by National Institutes of Health (NIH)
- Total publications:0 publications
Grant number: 75N92022D00015-0-759202300002-1
Grant search
Key facts
Disease
mpoxStart & end year
20232024Known Financial Commitments (USD)
$186,787Funder
National Institutes of Health (NIH)Principal Investigator
JULIE SULLIVANResearch Location
United States of AmericaLead Research Institution
Emory UniversityResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnosticsResearch Subcategory
DiagnosticsSpecial Interest Tags
N/AStudy Type
Non-ClinicalClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
Not ApplicableVulnerable Population
Not applicableOccupations of Interest
Not applicableMpox Research Priorities
Pathogen: natural history, transmission and diagnosticsMpox Research Sub Priorities
Development of equitable, accessible, safe & effective diagnostics (including POC)
Abstract
The National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADxÃ'®) Tech program has established the Independent Test Assessment Program (ITAP) in order to accelerate regulatory review and availability of high-quality, accurate, and reliable diagnostic tests.